Gossamer Bio Valuation
| GOSS Stock | USD 1.42 0.03 2.16% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Gossamer Bio retains a regular Real Value of $2.93 per share. The prevalent price of the firm is $1.42. Our model calculates the value of Gossamer Bio from evaluating the firm fundamentals such as Return On Equity of -1.23, current valuation of 236.94 M, and Return On Asset of -0.12 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Gossamer Bio's price fluctuation is very risky at this time. Calculation of the real value of Gossamer Bio is based on 3 months time horizon. Increasing Gossamer Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Gossamer stock is determined by what a typical buyer is willing to pay for full or partial control of Gossamer Bio. Since Gossamer Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gossamer Stock. However, Gossamer Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.42 | Real 2.93 | Hype 1.4 | Naive 1.59 |
The intrinsic value of Gossamer Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gossamer Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gossamer Bio helps investors to forecast how Gossamer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gossamer Bio more accurately as focusing exclusively on Gossamer Bio's fundamentals will not take into account other important factors: Gossamer Bio Total Value Analysis
Gossamer Bio is currently projected to have valuation of 236.94 M with market capitalization of 314.98 M, debt of 202.88 M, and cash on hands of 304.38 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Gossamer Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
236.94 M | 314.98 M | 202.88 M | 304.38 M |
Gossamer Bio Investor Information
About 76.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.25. Gossamer Bio had not issued any dividends in recent years. Based on the analysis of Gossamer Bio's profitability, liquidity, and operating efficiency, Gossamer Bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Gossamer Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Gossamer Bio has an asset utilization ratio of 36.38 percent. This implies that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Gossamer Bio is more efficient with each dollar of assets it utilizes for everyday operations.Gossamer Bio Ownership Allocation
Gossamer Bio has a total of 226.6 Million outstanding shares. The majority of Gossamer Bio outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Gossamer Bio to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Gossamer Bio. Please pay attention to any change in the institutional holdings of Gossamer Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Gossamer Bio Profitability Analysis
The company reported the previous year's revenue of 114.7 M. Net Loss for the year was (56.53 M) with profit before overhead, payroll, taxes, and interest of 114.7 M.About Gossamer Bio Valuation
The stock valuation mechanism determines Gossamer Bio's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Gossamer Bio based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gossamer Bio. We calculate exposure to Gossamer Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gossamer Bio's related companies.Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Gossamer Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 185 people.
Gossamer Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Gossamer Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 226.2 M |
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.